Press News

Press News

Press News | 25.02.2026

Print:
Title Media Publ. Date
Spyros Sapounas: Overconsumption of antibiotics Apogevmatini 25/02/2026
Why don’t breakthrough medicines reach Greece? Apogevmatini 25/02/2026
Companies in the U.S. are seeking compensation for the tariffs Kathimerini 25/02/2026
Dimitris Dentakis: The value of contributing, even to a single patient Kathimerini 25/02/2026

 

See here the publicity

 

Web Monitoring Report for the period 24/02 – 25/02

Title Media Publ. Date
Clinical trials: Now is the time for Europe to act – Benefits for 35,000 patients and the economy cnn.gr 24/02/2026
E. Agapidaki: 5.4 million unique beneficiaries, out of a total of 6 million under the National “Prolamvano” Program, have undergone the examinations ertnews.gr 24/02/2026
Greek pharma innovation faces bleak future, industry wants “urgent changes” euractiv.com 24/02/2026
Adonis Georgiadis: “I expect more medicine withdrawals from the market” healthreport.gr 25/02/2026
D. Papageorgiou (Takeda): Innovation is not sustainable with these rebates – How will therapies reach patients in time? healthstories.gr 24/02/2026
Clinical trials deliver remarkable added value for Europe in.gr 25/02/2026
Key points from the interview of Minister of Health Adonis Georgiadis on the program “Ataíriastoi” on SKAI TV moh.gov.gr 24/02/2026
Target for an 11% increase in clinical trials in Europe – An additional €4 billion for healthcare systems newsbomb.gr 24/02/2026
WHO Europe: On March 3, the “Quality for All” platform will be presented at the MoH parapolitika.gr 24/02/2026
National Plan needed for the holistic care of rare disease patients ygeiamou.gr 25/02/2026

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.